{"abstract": "Charles River, the pharmaceutical research company, told Jana Partners on Monday in a letter obtained by DealBook that its agreement to acquire WuXi PharmaTech, a research outsourcing company, was justified, despite the opposition of Jana, an activist hedge fund.", "web_url": "https://dealbook.nytimes.com/2010/06/15/charles-river-sticks-to-wuxi-despite-janas-critique/", "snippet": "Charles River, the pharmaceutical research company, told Jana Partners on Monday in a letter obtained by DealBook that its agreement to acquire WuXi PharmaTech, a research outsourcing company, was justified, despite the opposition of Jana, an acti...", "lead_paragraph": "Charles River, the pharmaceutical research company, told Jana Partners on Monday in a letter obtained by DealBook that its agreement to acquire WuXi PharmaTech, a research outsourcing company, was justified, despite the opposition of Jana, an activist hedge fund.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Charles River Sticks to WuXi Despite Jana\u2019s Critique", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "WuXi PharmaTech", "rank": 1, "major": "N"}, {"name": "glocations", "value": "China", "rank": 2, "major": "N"}], "pub_date": "2010-06-15T12:25:50+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/52773568-3bed-5852-97d6-d345deff2443", "word_count": 131, "uri": "nyt://article/52773568-3bed-5852-97d6-d345deff2443"}